Boehringer Ingelheim and Eli Lilly Alliance
This alliance leverages the companies’ strengths as two of the world’s leading pharmaceutical companies, combining Boehringer Ingelheim’s solid track record of research-driven innovation and Lilly’s innovative research, experience and pioneering history in diabetes.
Modules
EA:
1.5
MO:
RP:
Total:
1.5
On-demand webinar: Chronic kidney disease - what GPs can do to prevent progression and premature death
Audits
EA:
1.5
MO:
4
RP:
1
Total:
6.5
Clinical audit: Chronic kidney disease (CKD) - preventing progression and premature death in general practice
Audits
EA:
1
MO:
4
RP:
1
Total:
6
Clinical audit: Management of heart failure with reduced ejection fraction
Advanced courses
EA:
3
MO:
0
RP:
3.5
Total:
6.5
Heart failure in general practice: Putting latest recommendations into practice advanced course
Videos
EA:
MO:
RP:
Total:
0
Updated management of HFrEF in general practice